+44 (0) 20 7079 4399
Call HCA from 8am-8pm Mon-Fri and 9am-5pm Sat
HCA Healthcare UK
Mr Neil S Tolley
MB BCh, MD, FRCS (Eng and Ed), DLO
Head and neck cancers, Otolaryngology, Robotic Surgery
Sinus Surgery; Paediatric ENT and rhinology
Mr Neil Tolley was the first surgeon to use the da Vinci robot in the UK for Head and Neck Surgery. He underwent training in Strasbourg (2007), Geneva (2009), Paris (2009) and Philadelphia (2009) and now routinely performs robotic surgery at the Wellington Hospital, London. He has pioneered its use in Thyroid, Parathyroid and Transoral robotic surgery and has published and presented his work both nationally and internationally.To date (Feb 2012), he's the only surgeon in the UK capable of using the da Vinci robot for Thyroid surgery. He's a charter member of the Society of Robotic Surgeons and has presented his work at both World Congresses of Robotic Surgery held in Orlando (2010) and Miami (2011). Neil Tolley's NHS robotic work has been ethically approved. All patients are entered into a research protocol so that robotic techniques can be prospectively studied. This is important so that the advantages of robotic surgery can be scientifically evaluated. His pioneering robotic work has been published in peer reviewed journals. He routinely uses the da Vinci robot for Thyroidectomy and targeted Parathyroidectomy. His technique completely avoids a scar in the neck with no increase in hospital stay. Robotic techniques have a particular advantage in patients who scar badly, as in some dark skinned individuals. The avoidance of a neck scar is also advantageous in those patients who find it either culturally or cosmetically unacceptable to have a visible neck scar. All patients are admitted and discharged within 23 hours. Transoral robotic surgery has been used to treat cancer particularly in the tonsil region, where the incidence has increased 3 fold over the last 10 years because of its association with HPV (human papilloma virus). Robotic techniques permit the patient to be discharged within 7 days rather than undergoing extensive surgery with jaw-splitting and free flap reconstruction requiring a stay of 3 weeks. Furthermore, outcome measures such as swallowing have been found to be superior using the robot. These new surgical techniques permit treatment to be individually tailored and such pioneering work has allowed the avoidance of chemotherapy and significantly altered radiotherapy planning in many patients. This again has reduced the morbidity and long term consequences of receiving radiotherapy.
To Make an appointment, call HCA on +44(0)20 7079 4399
or click here
Call the contact centre
+44 (0) 20 7079 4399
8am-8pm Mon-Fri, 9am-5pm Sat
Let us call you backCan we call you back at a more convenient time
Email contact centreSend us an email and we will get back to you.
© copyright 2008 - 2017 HCA Healthcare UK.
Registered Name: HCA International Limited; The part of the UK in which it is registered: England and Wales;
Registered Number: 03020522; Registered Office Address: 242 Marylebone Road London NW1 6JL.
£500m has been invested by HCA International in the latest medical technologies and facilities over the last 10 years.
Your hospital will be one of our world-class private hospitals: HCA’s world-class hospitals are accredited by The CHKS Accreditation Unit, a leading provider of healthcare intelligence and quality improvement services. The accreditation is a measure of the overall quality of a hospital and hospitals with CHKS accreditation have been shown to provide a better quality of service.
Your safety will be protected because we have more critical care beds than any other private hospital group: HCA hospitals achieved 100% compliance with all Care Quality Commission inspected outcomes of care in 2011.
Your treatment will be undertaken using the most advanced diagnostic and treatment facilities: Oliver Wyman, Corporate Accounts: Driving quality and value, January 2012.